"/> Novus Biologicals™ Peptide bloquant d’anticorps Bo… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps Borealin

Réf. : BL-RE-053920Réf. fabricant : 18231907 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
55143
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77330. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 19 amino acids near the amino terminus of human Borealin.

Points forts

Source

Synthetic

(Accession #: NP_060571) The Borealin Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-053920
Réf. fabricant18231907
Gene ID (Entrez)55143
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77330. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneBOR, BOREALIN, cell division cycle associated 8, Cell division cycle-associated protein 8, Dasra B, DasraB, Dasra-B, FLJ10468, FLJ12042, hDasra-B, MESRGP, PESCRG3, Pluripotent embryonic stem cell-related gene 3 protein
Symbole de gène(s)CDCA8
Type de produitBorealin
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne19 amino acids near the amino terminus of human CDCA8
Une question, une configuration particulière ?
Contactez-nous pour un devis.